These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 28111112)
1. Intrauterine uterine contraception and chronic urticaria: a case series. Wunschel J; Poole JA Ann Allergy Asthma Immunol; 2017 Mar; 118(3):378-380. PubMed ID: 28111112 [No Abstract] [Full Text] [Related]
3. Hypertension and use of an intrauterine levonorgestrel-releasing device. Vos AG; van de Ree MA Neth J Med; 2012 Nov; 70(9):431. PubMed ID: 23123543 [No Abstract] [Full Text] [Related]
4. Severe seborrhoeic dermatitis: side-effect of the Mirena intra-uterine system. Karri K; Mowbray D; Adams S; Rendal JR Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):53-4. PubMed ID: 16546818 [TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel-releasing intrauterine system causes a lichenoid drug eruption. Jones JA; Shuler MJ; Zlotoff BJ Cutis; 2015 Jul; 96(1):E13-5. PubMed ID: 26244359 [No Abstract] [Full Text] [Related]
7. Endometrial adenocarcinoma in association with a levonorgestrel-releasing intrauterine system (Mirena). Ndumbe FM; Husemeyer RP J Fam Plann Reprod Health Care; 2006 Apr; 32(2):113-4. PubMed ID: 16824305 [No Abstract] [Full Text] [Related]
8. Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer. Neven P; Amant F; Poppe W; Van den Broecke R Fertil Steril; 2009 Apr; 91(4):e5; author reply e6. PubMed ID: 19249759 [No Abstract] [Full Text] [Related]
9. [Releasing Intrauterine System of Levonorgestrel and risk for breast cancer. ]. Scapinelli A; Oliveira VM; Takagi MM; Aldrighi JM Rev Assoc Med Bras (1992); 2010; 56(6):636-7. PubMed ID: 21271125 [No Abstract] [Full Text] [Related]
10. Headache associated with presence of IUS. Cooper C J Fam Plann Reprod Health Care; 2016 Jan; 42(1):75. PubMed ID: 26467508 [No Abstract] [Full Text] [Related]
11. Marked increase of breast density due to a levonorgestrel-releasing intrauterine device. Gossner J JBR-BTR; 2013; 96(6):396. PubMed ID: 24617194 [No Abstract] [Full Text] [Related]
12. Managing persistent ovarian follicles in premenopausal women fitted with the levonorgestrel-releasing intrauterine system. Morelli M; Di Cello A; Zullo F Int J Gynaecol Obstet; 2013 Feb; 120(2):187. PubMed ID: 23195289 [No Abstract] [Full Text] [Related]
13. IUDs and ectopic pregnancy. Sivin I Contraception; 1995 Nov; 52(5):321-2. PubMed ID: 8585891 [No Abstract] [Full Text] [Related]
14. Use of the levonorgestrel releasing-intrauterine system in nulliparous women--a non-interventional study in Sweden. Marions L; Lövkvist L; Taube A; Johansson M; Dalvik H; Øverlie I Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):126-34. PubMed ID: 21417562 [TBL] [Abstract][Full Text] [Related]
15. The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception. Mansour D Contraception; 2012 Mar; 85(3):224-34. PubMed ID: 22067761 [TBL] [Abstract][Full Text] [Related]
16. Heterotopic cesarean scar pregnancy associated with a levonorgestrel-releasing intrauterine device. Dueñas-Garcia OF; Young C Int J Gynaecol Obstet; 2011 Aug; 114(2):153-4. PubMed ID: 21679948 [No Abstract] [Full Text] [Related]
17. Pseudo-decidual reaction to Mirena coil in a cervical smear: a potential diagnostic pitfall for false-positive cervical cytology. Hughes C; Woods J; Turner L; Gibbons D Cytopathology; 2005 Oct; 16(5):268-9. PubMed ID: 16181320 [No Abstract] [Full Text] [Related]
18. [A case report. Sepsis in connection with levonorgestrel IUD]. Ottander U; Bäckström T; Högberg U; Löfgren M Lakartidningen; 1995 Nov; 92(48):4555-7. PubMed ID: 7490972 [No Abstract] [Full Text] [Related]